Labshake search
Citations for Stemcell Technologies :
151 - 200 of 1312 citations for 7 6 7 dimethoxy 3 4 dihydroisoquinolin 1 yl 2 methyl 3 2 methylphenyl quinazolin 4 one since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2023Quote: IMR90-4 iPSCs (WiCell, Madison, WI) were cultured on Matrigel-coated 6-well plates and supplemented daily with E8 medium (Stem Cell Technologies) as described (81) ...
-
bioRxiv - Bioengineering 2021Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). On the following day ...
-
bioRxiv - Cancer Biology 2019Quote: ... IL-3/G-CSF–producing M2-10B4 and IL-3/KL-producing SI/SI murine fibroblasts in MyeloCult H5100 (StemCell Technologies) supplemented with hydrocortisone ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 ng/mL recombinant human FMS-like tyrosine kinase 3 ligand (Flt-3) and 10 ng/mL recombinant human thrombopoietin (TPO; StemCell Technologies). After sublethal conditioning of 9-12 weeks old Gaa−/− mice with 7.5 Gy gamma-irradiation (1.6 Gy/min ...
-
bioRxiv - Neuroscience 2023Quote: ... Each plate was then split 1:2 using ReLeSR (StemCell Technologies), with half of the cells used for DNA extraction for Sanger sequencing ...
-
Arc mediates intercellular synaptic plasticity via IRSp53-dependent extracellular vesicle biogenesisbioRxiv - Neuroscience 2024Quote: ... 2% SM1 (StemCell Technologies), 500 µM L-Glutamine ...
-
bioRxiv - Developmental Biology 2023Quote: ... we added 4-hydroxytamoxifen freshly prepared in ethanol as per manufacturer instructions (4-OHT) (Stem Cell Technologies, 72662) to the medium at 0.1µM at the indicated time points.
-
bioRxiv - Biochemistry 2023Quote: ... 4 μg/mL heparin (STEMCELL Technologies, 07980) and 5 μM ROCK inhibitor (Millipore) ...
-
bioRxiv - Neuroscience 2021Quote: ... the cells were counted and 2 million were cultured for 6 days in hematopoietic expansion media -Stemspan H3000(Stemcell Technologies), with the addition of EPO (R&D) ...
-
bioRxiv - Neuroscience 2021Quote: ... Transfected cells were plated in 2 wells of a 6-well plate with mTeSR1 media supplemented with CloneR (STEMCELL Technologies) to enhance cell survival ...
-
bioRxiv - Bioengineering 2023Quote: ... supplemented with 2 μl/mL ROCKi and seeded into microwells (6-well AggreWellTM 400 plates, Stem Cell Technologies, cat. 34460) at a density of 800–1,000 cells per microwell using the manufacturer’s recommended protocol ...
-
bioRxiv - Bioengineering 2019Quote: ... and cultured at 37°C (5% CO2) for 7 days in 300 µL StemSpan™ SFEM (#09650 Stemcell Technologies) supplemented with 100 ng/mL SCF (Peprotech ...
-
bioRxiv - Immunology 2021Quote: ... Both cell types were passaged every 7 days or as they reached 70-80% confluency using ReLeSR (STEMCELL Technologies). All iPSC and ESC lines used for these studies are listed in Table 1 along with the method of reprogramming and institution they were reprogrammed at ...
-
bioRxiv - Cell Biology 2024Quote: ... mesoderm was carried out for 5 days and ectoderm for 7 days using STEMdiff Trilineage Differentiation Kit (STEMCELL Technologies). Alternatively ...
-
bioRxiv - Developmental Biology 2022Quote: ... containing 3 μM CHIR99021 (Stem Cell Technologies, Cat.#72054), 500 μg/mL bovine serum albumin (BSA ...
-
bioRxiv - Neuroscience 2021Quote: ... 20ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin (Thermo Fisher ...
-
bioRxiv - Cancer Biology 2021Quote: ... containing 3 mL Methocult GF H4230 (Stem Cell Technologies) and plated in triplicate in 35 mm gridded plates and incubating for 8-10 d.
-
bioRxiv - Immunology 2023Quote: ... and IL-3 (10 ng/mL; Stem Cell Technologies). After 5 days ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Neuroscience 2024Quote: ... Cells were passaged 1-2 times per week with ReLeSR (STEMCELL Technologies) when they reached 80-90% confluence ...
-
bioRxiv - Developmental Biology 2021Quote: ... Definitive endoderm cells are then differentiated into anterior ventral foregut endoderm (Stage 2) using dual SMAD inhibition for 2 days with 2 µM Dorsomorphin (STEMCELL Technologies, cat#72102) and 10 µM SB431542 (STEMCELL Technologies ...
-
bioRxiv - Neuroscience 2022Quote: ... Single cells were plated (2 x 106/well) in Matrigel-coated 6-well plate in mTeSR1 plus growth medium (STEMCELL Technologies), supplemented with 10 mM Y-27632 ROCK inhibitor (Calbiochem ...
-
bioRxiv - Synthetic Biology 2022Quote: ... Two days post-transfection, the cells were replated in a 6 well (Falcon, 353224) and selected in 2 μg/ml Puromycin (STEMCELL Technologies). Every two days ...
-
bioRxiv - Cancer Biology 2023Quote: The six basal- and luminal-like cell lines were disassociated with 0.25% trypsin and added individually to wells of a 6 well Ultra-low attachment plate in 2 mL Mammocult culturing media (STEMCELL Technologies). Accutase (STEMCELL Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... 1.1ml of the mixture (2 x 104 BM cells and 2 x 105 spleen cells) was plated in triplicate into 6-well dishes (SmartDishTM, STEMCELL Technology). After incubation for 10 days ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Immunology 2021Quote: ... The preparation was centrifuged (200 g; 7 min) and the pellet resuspended in PneumaCult-Ex Plus expansion medium (Stemcell Technologies), then seeded onto 25 cm2 tissue culture flasks pre-coated with 30 µg/mL Type I collagen (PureCol ...
-
bioRxiv - Neuroscience 2022Quote: ... NSPC cultures were then passaged every 7 days by enzymatic disaggregation with Accutase (cat# 7920, Stem Cell Technologies, Vancouver, Canada). The medium was supplemented with Neurocult proliferation supplement (cat# 05702 ...
-
bioRxiv - Developmental Biology 2022Quote: ... IPSC colonies were picked and passaged every 5 to 7 days after transfer to the mTeSR culture system (Stemcell Technologies).
-
bioRxiv - Bioengineering 2019Quote: ... or APEL 2 (STEMCELL Technologies) media without ROCK inhibitor and plates were placed onto LAVA illumination devices and subjected to experimental conditions ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 µM XAV939 (STEMCELL Technologies), 10 µM SB431542 hydrate and 2 µg/mL doxycycline hyclate (Sigma) ...
-
bioRxiv - Pathology 2022Quote: ... 2 µM CHIR99021 (StemCell Technologies), and 10 ng/mL Recombinant Human BMP-7(Peprotech) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2% SM1 (Stem Cell Technologies), 15mM HEPES (Gibco) ...
-
bioRxiv - Neuroscience 2023Quote: ... IWP-2 (STEMCELL Technologies, 72124), RA (Sigma ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2 μM SB431542 (StemCell Technologies), 1 μM DMH1 (Tocris Bioscience) ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Bioengineering 2023Quote: ... (StemCell Technologies, #129830-38-2) in mTeSR-1 media ...
-
bioRxiv - Neuroscience 2024Quote: ... 2% SM1 (05711, STEMCell Technologies), 1% N2 (07152 ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with 4 µg/mL heparin (STEMCELL Technologies), 480 ng/mL hydrocortisone ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 μg/ml heparin (Stem cell technologies; #07980), 20 ng/ml Animal-Free Recombinant Human EGF (Peprotech ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... 4 µg/mL Heparin (StemCell Technologies, cat. 07980), and 400 nL/mL B27 (Invitrogen ...
-
bioRxiv - Cell Biology 2020Quote: ... N2B27 medium was supplemented with 3 µM CHIR (STEMCELL Technologies) and 100 ng/mL Activin A (Biotechne) ...
-
bioRxiv - Cell Biology 2020Quote: ... Cells were passaged every 3 days using Relesr (STEMCELL Technologies) and supplemented with Rock Inhibitor Y-27632 (SelleckChem ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml IL-3 (STEMCELL Technologies; Cat. No. 78042) was directly added to the medium to support growth in the absence of an oncogene ...
-
bioRxiv - Microbiology 2022Quote: ... 20 ng/ml NT-3 (Stem Cell Technologies Cat # 78074), and Penicillin/Streptomycin cocktail ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (Chir) (Catalog no. 72054, Stem Cell Technologies), 1 μM PD0305901 (Catalog no ...
-
bioRxiv - Genomics 2021Quote: ... onto Matrigel-coated (1 mg ml-1) 6-well plates 6 using ReLeSR (STEMCELL Technologies). Cells were differentiated to CD43+ hematopoietic progenitors using the StemCell Technologies Hematopoietic Kit (Cat #05310) ...
-
bioRxiv - Genomics 2020Quote: ... Tissues were minced into ~1-2 mm pieces and digested with 1× Collagenase/Hyaluronidase (STEMCELL Technologies) and 100 μg/mL DNase I (Sigma-Aldrich ...